January 29, 2026
IRA Medicare Drug Price Negotiation: Round Three Expected in 2028 with Reforms Aimed at Pharma Manageability
IRA negotiations; Medicare drug prices; Round three; pharma impact; pill penalty; Executive Order 14273
Eikon and Veradermics Announce IPO Targets Amid Biotech Market Optimism
Eikon Therapeutics; Veradermics; IPO; biotech; hair loss; cancer drugs; Nasdaq; NYSE
HHS Issues Guidance to Shield Pharma from Anti-Kickback Violations in TrumpRx Direct-to-Consumer Drug Sales
TrumpRx; HHS; anti-kickback statute; direct-to-consumer; prescription drugs; OIG bulletin
Formation Bio Eyes Abivax-Like Success with Chinese Drug Licensing Deal Targeting Same Mechanism
Formation Bio; Abivax; licensing deal; China; cancer drug; PD-1/VEGF; biotech
Unravel Biosciences and The SCN2A Foundation Announce Drug Discovery Collaboration
Unravel Biosciences; SCN2A Foundation; drug discovery; SCN2A mutations; autism; epilepsy; loss-of-function; AI therapeutics
Seno Medical’s Next-Generation Imagio Imaging System Receives EU MDR CE Mark Certification
Seno Medical; Imagio Imaging System; EU MDR CE Mark; opto-acoustic imaging; breast cancer diagnostics; Model 9100
Spotlight On: AI in Genomics and Multimodal Data Analysis Loosens Orphan Drug R&D Bottlenecks
AI; genomics; multimodal data; orphan drugs; rare diseases; drug discovery; drug repurposing
Convergent Therapeutics Appoints Elizabeth L. Montgomery as Chief People Officer
Convergent Therapeutics; Elizabeth Montgomery; CPO; biotechnology; radiopharmaceuticals; appointment
Pacira BioSciences Appoints Samit Hirawat, M.D., to Board of Directors
Pacira BioSciences; Samit Hirawat; Board of Directors; appointment; non-opioid pain therapies